President Obama to provide federal funding for Alzheimer’s programs

Monday, December 26th, 2011

As the world’s leading voluntary health organization advocating for Alzheimer’s care, support and research, the Alzheimer’s Association is pleased that Congress and President Obama have responded to calls by the Alzheimer’s Association on behalf of people with Alzheimer’s disease, caregivers, health professionals and researchers, to provide federal funding for several ... continue reading

New drug could be the first to prevent the progression of Alzheimer’s disease

Monday, December 19th, 2011

Anyone who has watched as Alzheimer’s disease robs a friend or family member of their memories and faculties before ultimately claiming their life knows just what a truly horrible disease it is. According to the World Health Organization, it is the fourth leading cause of death in high-income countries and, ... continue reading

Alzheimer’s Association applauds hero Sherry Pearce

Friday, September 30th, 2011

With more than 35 million people living with dementia around the world and nearly 15 million Americans caring for a loved one with Alzheimer’s, this global epidemic demands the same attention as its…

See the original post:
Alzheimer’s Association applauds hero Sherry ... continue reading

September Marks World Alzheimer’s Month as Advocates Push for Early Diagnosis and Health Care Planning

Wednesday, September 21st, 2011

September is World Alzheimer’s Month, and September 21st is Alzheimer’s Action Day. In New York, more than 320,000 people are living with Alzheimer’s disease and more than 229,500 of them are in nursing homes. Unfortunately, someone develops Alzheimer’s disease every 69 seconds nationwide. Estimates show that by 2050 more than ... continue reading

Global Standardization For Alzheimer’s Biomarkers Moves A Major Step Closer To Reality

Sunday, August 14th, 2011

Citeline, an Informa business unit, and the world’s leading research authority on pharmaceutical clinical trials recently reviewed the findings from the 14th International Conference on Alzheimer’s Disease (ICAD 2011/AAIC 2011) July 16-21, 2011, noting that while pharma continues to develop beta amyloid targeting drugs, amyloid targets are moving ahead in ... continue reading